GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 421 filers reported holding GUARDANT HEALTH INC in Q2 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $697,755 | -11.4% | 23,541 | +7.0% | 0.00% | 0.0% |
Q2 2023 | $787,958 | +84.3% | 22,010 | +20.7% | 0.00% | +50.0% |
Q1 2023 | $427,428 | -5.1% | 18,235 | +10.1% | 0.00% | 0.0% |
Q4 2022 | $450,514 | -42.1% | 16,563 | +14.5% | 0.00% | -60.0% |
Q3 2022 | $778,000 | +42.5% | 14,461 | +6.9% | 0.01% | +66.7% |
Q2 2022 | $546,000 | -39.8% | 13,526 | -1.2% | 0.00% | -25.0% |
Q1 2022 | $907,000 | -39.4% | 13,689 | -8.5% | 0.00% | -42.9% |
Q4 2021 | $1,496,000 | +4.1% | 14,961 | +30.2% | 0.01% | -12.5% |
Q3 2021 | $1,437,000 | +4.3% | 11,492 | +3.6% | 0.01% | 0.0% |
Q2 2021 | $1,378,000 | -16.9% | 11,092 | +2.1% | 0.01% | -20.0% |
Q1 2021 | $1,658,000 | +44.7% | 10,859 | +22.1% | 0.01% | +42.9% |
Q4 2020 | $1,146,000 | +62.3% | 8,892 | +40.9% | 0.01% | +40.0% |
Q3 2020 | $706,000 | +37.9% | 6,313 | 0.0% | 0.01% | +25.0% |
Q2 2020 | $512,000 | +138.1% | 6,313 | +104.1% | 0.00% | +100.0% |
Q1 2020 | $215,000 | +20.1% | 3,093 | +35.2% | 0.00% | +100.0% |
Q4 2019 | $179,000 | +22.6% | 2,288 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $146,000 | +92.1% | 2,288 | +160.0% | 0.00% | 0.0% |
Q2 2019 | $76,000 | – | 880 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 676,047 | $20,038,033 | 18.92% |
Deep Track Capital, LP | 4,050,000 | $120,042,000 | 4.63% |
Eventide Asset Management | 3,589,530 | $106,393,669 | 1.91% |
Adalta Capital Management LLC | 81,220 | $2,408 | 1.64% |
Eagle Health Investments LP | 204,861 | $6,072,080 | 1.34% |
Integral Health Asset Management, LLC | 325,000 | $9,633,000 | 1.33% |
Sicart Associates LLC | 95,925 | $2,843,217 | 1.12% |
Aristotle Atlantic Partners, LLC | 834,096 | $24,722,605 | 0.99% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,329,935 | $39,419,273 | 0.87% |
BRANDYWINE MANAGERS, LLC | 15,933 | $472,254 | 0.80% |